MSD Pharma Hungary, Pécs U Sign Cooperation Deal
Image by JeanLucIchard / Shutterstock.com
MSD Pharma Hungary, the local unit of U.S.-based drug maker Merck, signed a cooperation agreement with the University of Pécs on Thursday, the school told MTI.
The goal of the partnership is to speed up the start of clinical trials, the university said.
Szabolcs Barótfi, MSD's clinical research director in Hungary, said the company was sponsoring 26 clinical trials with the participation of 60 patients at the University of Pécs at present. Three-fourths of participants are being treated for cancer, he added.
MSD spends around HUF 3 bln to conduct clinical trials in Hungary each year.
ÁKK Sells HUF 82.5 bln of Bonds at Auction, Above Plan
EC Puts Hungary 2024 GDP Growth at 2.4%
HU-rizon Program: HUF 8 bln Funding for International Resear...
Inspiring Women at the Focus of Gourmet Fest
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
